UK Industry Lambasts Government For High Rebates In Proposed New Statutory Pricing Scheme

Proposed changes to the UK statutory pricing scheme from 2024 would see a slight drop in the rebate rate compared with that applied to drug sales this year, but the ABPI warns that the clawbacks planned are still much too high and that the move could undermine talks on a new voluntary scheme.